Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted)
Emergent BioSolutions獲得來自Barda的5000萬美元合同選項,以採購Cyfendus®(吸附炭疽生物-疫苗,增強劑)劑量
Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted)
Emergent BioSolutions獲得來自Barda的5000萬美元合同選項,以採購Cyfendus®(吸附炭疽生物-疫苗,增強劑)劑量
譯文內容由第三人軟體翻譯。